|
|
|
|
|
|
Bellicum Pharma Comm (BLCM)
|
|
13.39 -0.59 (-4.22%)
|
6/23/2017 4:00pm
|
|
Open:
|
14.24
|
Pre. Close:
|
13.98
|
|
High:
|
14.49
|
Low:
|
12.80
|
|
Volume:
|
2,776,877
|
Market Cap:
|
443.25M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
14.51 - 14.82
|
14.82 - 15.23
|
|
Low:
|
11.74 - 12.09
|
12.09 - 12.56
|
|
Close:
|
12.46 - 13.01
|
13.01 - 13.75
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:32:41 PM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 16.92  One year: 19.77
|
|
Support:
|
Support1: 11.61 Support2: 9.83
|
|
Resistance:
|
Resistance1:
14.49 Resistance2: 16.92
|
|
Pivot:
|
11.52
|
|
Moving Averages:
|
MA(5): 13.16 MA(20): 11.56
MA(100): 12.70 MA(250): 15.17
|
|
MACD:
|
MACD(12,26):
0.20 Signal(12,26,9): -0.19
|
|
%K %D:
|
%K(14,3): 82.81 %D(3): 83.46
|
|
RSI:
|
RSI(14): 61.89
|
|
52-Week:
|
High: 23.11
Low: 9.71 Change(%): 3.1
|
|
Average Vol(K):
|
3-Month: 670
10-Days 1293
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.BLCM has closed below upper band by 11.6%. Bollinger Bands are 91.9% wider than normal. The large width of the bands suggest high volatility as compared to BLCM's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Fri, 23 Jun 2017 18:56:15 GMT
Despite A Volatile Trading Week, Bellicum's EHA Presentation Merits A Second Look
Tue, 20 Jun 2017 12:56:15 GMT
What's Gotten Into Bellicum Pharmaceuticals?
Fri, 23 Jun 2017 11:03:45 GMT
Bellicum Pharma (BLCM) Presents Clinical Data on BPX-501 at Presidential Symposium
Sun, 25 Jun 2017 04:07:30 GMT
Bellicum Pharmaceuticals, Inc. (NasdaqGM:BLCM): Rundown of the Numbers & Valuation
Fri, 23 Jun 2017 15:59:53 GMT
Why Investors remained buoyant on: Intercontinental Exchange, Inc. (ICE ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
